These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 19256273

  • 1. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
    Virzi S, Iusco D, Grassi A, Navarra G, Ismail I, Panetta A, Bonomi S.
    Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A, Borzellino G, Momo EN, Segattini C, Pitoni F, Steccanella F, De Manzoni G.
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [Abstract] [Full Text] [Related]

  • 3. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [Abstract] [Full Text] [Related]

  • 4. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
    Kecmanovic DM, Pavlov MJ, Ceranic MS, Sepetkovski AV, Kovacevic PA, Stamenkovic AB.
    Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA.
    J Clin Oncol; 2003 Oct 15; 21(20):3737-43. PubMed ID: 14551293
    [Abstract] [Full Text] [Related]

  • 6. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.
    In Vivo; 2009 Oct 15; 23(4):639-44. PubMed ID: 19567401
    [Abstract] [Full Text] [Related]

  • 7. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P, Coffin B, Parmentier G, Hay JM, Flamant Y, Msika S.
    Eur J Surg Oncol; 2008 Nov 15; 34(11):1246-52. PubMed ID: 18222622
    [Abstract] [Full Text] [Related]

  • 8. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin.
    Glehen O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN.
    Br J Surg; 2004 Jun 15; 91(6):747-54. PubMed ID: 15164446
    [Abstract] [Full Text] [Related]

  • 9. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.
    Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA.
    Ann Surg Oncol; 2004 Apr 15; 11(4):375-9. PubMed ID: 15070596
    [Abstract] [Full Text] [Related]

  • 10. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Iversen LH, Rasmussen PC, Laurberg S.
    Ugeskr Laeger; 2007 Sep 17; 169(38):3179-81. PubMed ID: 17910824
    [Abstract] [Full Text] [Related]

  • 11. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer.
    Franko J, Gusani NJ, Holtzman MP, Ahrendt SA, Jones HL, Zeh HJ, Bartlett DL.
    Ann Surg Oncol; 2008 Nov 17; 15(11):3065-72. PubMed ID: 18712450
    [Abstract] [Full Text] [Related]

  • 12. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L, Yan TD, Sugarbaker PH.
    Ann Surg Oncol; 2007 Aug 17; 14(8):2281-8. PubMed ID: 17503156
    [Abstract] [Full Text] [Related]

  • 13. [Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute].
    Zoetmulder FA, van der Vange N, Witkamp AJ, Kaag MM, Boot H, Beijnen JH.
    Ned Tijdschr Geneeskd; 1999 Sep 11; 143(37):1863-8. PubMed ID: 10526600
    [Abstract] [Full Text] [Related]

  • 14. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y.
    Ann Surg Oncol; 2009 Feb 11; 16(2):345-51. PubMed ID: 19018599
    [Abstract] [Full Text] [Related]

  • 15. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J.
    Ann Surg Oncol; 2012 Jul 11; 19(7):2186-94. PubMed ID: 22395983
    [Abstract] [Full Text] [Related]

  • 16. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].
    Pocard M, Boige V.
    Bull Cancer; 2005 Feb 11; 92(2):151-4. PubMed ID: 15749644
    [Abstract] [Full Text] [Related]

  • 17. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FA.
    Br J Surg; 2004 Jun 11; 91(6):739-46. PubMed ID: 15164445
    [Abstract] [Full Text] [Related]

  • 18. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
    Chua TC, Pelz JO, Kerscher A, Morris DL, Esquivel J.
    Ann Surg Oncol; 2009 Oct 11; 16(10):2765-70. PubMed ID: 19641972
    [Abstract] [Full Text] [Related]

  • 19. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
    Cavaliere F, Di Filippo F, Botti C, Cosimelli M, Giannarelli D, Aloe L, Arcuri E, Aromatario C, Consolo S, Callopoli A, Laurenzi L, Tedesco M, Di Angelo P, Giunta S, Cavaliere R.
    Eur J Surg Oncol; 2000 Aug 11; 26(5):486-91. PubMed ID: 11016471
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M.
    Ann Surg Oncol; 2007 Aug 11; 14(8):2300-8. PubMed ID: 17510772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.